Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 12 | 2025 | 112 | 3.010 |
Why?
|
| Lymphatic Abnormalities | 5 | 2022 | 36 | 2.320 |
Why?
|
| Hemangioma | 8 | 2024 | 97 | 2.160 |
Why?
|
| Sirolimus | 9 | 2024 | 241 | 1.590 |
Why?
|
| Hemangioendothelioma | 4 | 2020 | 25 | 1.370 |
Why?
|
| Kasabach-Merritt Syndrome | 3 | 2020 | 16 | 1.220 |
Why?
|
| Sarcoma, Kaposi | 3 | 2020 | 131 | 1.100 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2021 | 128 | 0.910 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2024 | 7 | 0.900 |
Why?
|
| Lymphangioma | 2 | 2021 | 24 | 0.870 |
Why?
|
| Chylothorax | 2 | 2021 | 28 | 0.860 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 46 | 0.780 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2023 | 53 | 0.780 |
Why?
|
| Osteolysis, Essential | 1 | 2021 | 4 | 0.710 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2021 | 16 | 0.700 |
Why?
|
| Pleural Effusion | 1 | 2021 | 109 | 0.680 |
Why?
|
| Vascular Neoplasms | 1 | 2020 | 33 | 0.660 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 1306 | 0.630 |
Why?
|
| Arteriovenous Malformations | 3 | 2024 | 48 | 0.590 |
Why?
|
| Embolization, Therapeutic | 3 | 2024 | 224 | 0.490 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 32 | 0.450 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 1386 | 0.410 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 897 | 0.410 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2023 | 8 | 0.400 |
Why?
|
| Child | 22 | 2025 | 25761 | 0.380 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2011 | 20 | 0.350 |
Why?
|
| Lymphatic Vessels | 2 | 2021 | 36 | 0.340 |
Why?
|
| Upper Extremity | 1 | 2011 | 55 | 0.340 |
Why?
|
| Infant | 15 | 2025 | 13040 | 0.320 |
Why?
|
| Humans | 42 | 2025 | 132083 | 0.320 |
Why?
|
| Blood Vessels | 1 | 2010 | 106 | 0.320 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 79 | 0.310 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 173 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 215 | 0.300 |
Why?
|
| Consensus | 2 | 2024 | 656 | 0.290 |
Why?
|
| Infant, Newborn | 10 | 2024 | 8539 | 0.290 |
Why?
|
| Thrombocytopenia | 2 | 2021 | 234 | 0.280 |
Why?
|
| Drainage | 2 | 2021 | 265 | 0.280 |
Why?
|
| Neutropenia | 2 | 2020 | 205 | 0.280 |
Why?
|
| Ascites | 2 | 2018 | 103 | 0.270 |
Why?
|
| Congenital Abnormalities | 1 | 2010 | 300 | 0.260 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 257 | 0.250 |
Why?
|
| Proteus Syndrome | 1 | 2025 | 1 | 0.240 |
Why?
|
| Splenic Vein | 1 | 2025 | 11 | 0.230 |
Why?
|
| Splenic Artery | 1 | 2025 | 22 | 0.230 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 84 | 0.230 |
Why?
|
| Epistaxis | 1 | 2024 | 12 | 0.220 |
Why?
|
| Splenectomy | 1 | 2025 | 62 | 0.220 |
Why?
|
| Lymphatic System | 2 | 2021 | 19 | 0.220 |
Why?
|
| Spleen | 1 | 2025 | 272 | 0.210 |
Why?
|
| Purpura | 1 | 2023 | 26 | 0.200 |
Why?
|
| Arteriovenous Fistula | 1 | 2023 | 55 | 0.200 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2022 | 33 | 0.200 |
Why?
|
| Delphi Technique | 1 | 2024 | 240 | 0.190 |
Why?
|
| Child, Preschool | 9 | 2025 | 14719 | 0.190 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17367 | 0.190 |
Why?
|
| Octreotide | 1 | 2021 | 24 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 72 | 0.180 |
Why?
|
| Lymphedema | 1 | 2021 | 21 | 0.180 |
Why?
|
| Otolaryngology | 1 | 2023 | 108 | 0.180 |
Why?
|
| Angiomatosis | 1 | 2021 | 6 | 0.180 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 31 | 0.170 |
Why?
|
| Rhabdomyoma | 1 | 2021 | 15 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2022 | 152 | 0.170 |
Why?
|
| Hemangioma, Capillary | 1 | 2020 | 17 | 0.160 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2020 | 44 | 0.160 |
Why?
|
| Male | 17 | 2025 | 64904 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 105 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 46 | 0.160 |
Why?
|
| Accelerated Idioventricular Rhythm | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ethiodized Oil | 1 | 2019 | 4 | 0.160 |
Why?
|
| Muscle Weakness | 1 | 2020 | 93 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 87 | 0.150 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2019 | 20 | 0.150 |
Why?
|
| Thrombosis | 1 | 2023 | 530 | 0.150 |
Why?
|
| Peritoneovenous Shunt | 1 | 2018 | 5 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 634 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 256 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 169 | 0.140 |
Why?
|
| Chylous Ascites | 1 | 2017 | 11 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 186 | 0.140 |
Why?
|
| Female | 14 | 2025 | 70664 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2024 | 1098 | 0.140 |
Why?
|
| Critical Illness | 1 | 2021 | 617 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 314 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 249 | 0.130 |
Why?
|
| Prognosis | 4 | 2020 | 5006 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1010 | 0.130 |
Why?
|
| Thrombocytosis | 1 | 2017 | 34 | 0.130 |
Why?
|
| Medical Oncology | 1 | 2018 | 243 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 672 | 0.130 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 102 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1596 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 215 | 0.120 |
Why?
|
| Anemia | 1 | 2020 | 349 | 0.120 |
Why?
|
| Mutation | 4 | 2025 | 6248 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 615 | 0.120 |
Why?
|
| Young Adult | 4 | 2025 | 9935 | 0.110 |
Why?
|
| Iron Chelating Agents | 1 | 2014 | 15 | 0.110 |
Why?
|
| Iron Overload | 1 | 2014 | 16 | 0.110 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 39 | 0.110 |
Why?
|
| Adolescent | 9 | 2025 | 20532 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 113 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1332 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2020 | 700 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 830 | 0.100 |
Why?
|
| Registries | 1 | 2018 | 1589 | 0.090 |
Why?
|
| Leukemia | 1 | 2014 | 373 | 0.090 |
Why?
|
| Lymphoma | 1 | 2014 | 331 | 0.090 |
Why?
|
| Radiology, Interventional | 2 | 2022 | 35 | 0.080 |
Why?
|
| Algorithms | 2 | 2025 | 1724 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2022 | 3144 | 0.080 |
Why?
|
| Pregnancy | 1 | 2023 | 7551 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2010 | 58 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3854 | 0.080 |
Why?
|
| Pediatrics | 1 | 2018 | 1208 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2011 | 700 | 0.070 |
Why?
|
| Adult | 4 | 2025 | 31544 | 0.070 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 228 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2007 | 36 | 0.070 |
Why?
|
| United States | 2 | 2023 | 11630 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2007 | 45 | 0.070 |
Why?
|
| Connexins | 1 | 2007 | 64 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2023 | 13014 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2023 | 1967 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 4541 | 0.060 |
Why?
|
| Aminopyridines | 1 | 2025 | 55 | 0.060 |
Why?
|
| Splenic Diseases | 1 | 2025 | 31 | 0.060 |
Why?
|
| Lumbosacral Region | 1 | 2024 | 25 | 0.050 |
Why?
|
| Imidazoles | 1 | 2025 | 219 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2023 | 107 | 0.050 |
Why?
|
| Propranolol | 1 | 2023 | 112 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2022 | 5 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2022 | 34 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 623 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2512 | 0.050 |
Why?
|
| Capillaries | 1 | 2022 | 71 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1975 | 0.050 |
Why?
|
| Sclerotherapy | 1 | 2022 | 39 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2023 | 221 | 0.050 |
Why?
|
| Urogenital Abnormalities | 1 | 2024 | 167 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 198 | 0.050 |
Why?
|
| Endothelium, Lymphatic | 1 | 2021 | 9 | 0.040 |
Why?
|
| Syndrome | 1 | 2024 | 1173 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2020 | 19 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 377 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2020 | 35 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 97 | 0.040 |
Why?
|
| Vomiting | 1 | 2020 | 108 | 0.040 |
Why?
|
| Fatigue | 1 | 2020 | 198 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 780 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 982 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5399 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2018 | 100 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2010 | 4725 | 0.030 |
Why?
|
| Peritoneum | 1 | 2017 | 39 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 310 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 146 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 2059 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2019 | 225 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2017 | 48 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 208 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 152 | 0.030 |
Why?
|
| Chelation Therapy | 1 | 2014 | 2 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2922 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3738 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 508 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 822 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2706 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 258 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3982 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 2152 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1581 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6530 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3201 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 34951 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3358 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3083 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1102 | 0.020 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2007 | 8 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 19 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 370 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 611 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 493 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 10899 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3698 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 18565 | 0.000 |
Why?
|